xMD Diagnostics
Annapolis, US · Maryland corporation · 2 known investors
xMD Diagnostics develops laboratory instruments and consumables for molecular diagnostics, aimed at enriching samples for downstream molecular testing. It serves research, biopharmaceutical, and clinical (CLIA) laboratories to help pathologists, oncologists, and other physicians diagnose, monitor, and treat cancer and other genetic diseases.
Founders & leadership



Board

Investors · 2
Reported raises · per SEC filings
Form D private placements$675K disclosed across 2 rounds · 2017–2018
▶$500KraisedOct 2018 · 1 investors · BiotechnologyRule 506(b)
- Stephen R. RitterbushExecutive Officer, Director
- Ting Pau OeiExecutive Officer, Director
- Benjamin ShapiroExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $500K
- First sale
- Oct 2018
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
▶$175KraisedMar 2017 · 1 investors · BiotechnologyRule 506(b)
- Al FleuryExecutive Officer
- Michael Emmert-BuckExecutive Officer
- Ting Pau OeiExecutive Officer, Director
- Benjamin ShapiroExecutive Officer, Director
- Stephen RitterbushExecutive Officer, Director
- Offering amount
- $350K
- Amount sold
- $175K
- Proceeds to insiders
- $35K
- First sale
- Jan 2017
- Incorporated
- Limited Liability Company, Maryland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapCompanies competing with xMD Diagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2021 | $256K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does xMD Diagnostics do?
- xMD Diagnostics develops laboratory instruments and consumables for molecular diagnostics, aimed at enriching samples for downstream molecular testing. It serves research, biopharmaceutical, and clinical (CLIA) laboratories to help pathologists, oncologists, and other physicians diagnose, monitor, and treat cancer and other genetic diseases.
- Who founded xMD Diagnostics?
- xMD Diagnostics was founded by Benjamin Shapiro.
- Who are xMD Diagnostics's investors?
- xMD Diagnostics's investors include Maryland TEDCO, TEDCO.
- How much funding has xMD Diagnostics raised?
- xMD Diagnostics has disclosed $675K raised across 2 rounds.
- Where is xMD Diagnostics headquartered?
- xMD Diagnostics is headquartered in Annapolis, US.

